In-Vitro Diagnostics
In-Vitro Diagnostics
The in vitro diagnostics market includes analyzers and reagents used for performing assays in vitro, which can be interpreted as a controlled environment outside of the living organism. This market includes revenues for select segments of immunochemistry, molecular diagnostics, blood donor screening, hemostasis, hematology and point-of-care testing.
“I was impressed with the depth and breadth of information contained in the report.”
-Jordan Fein, Marketing Research Analyst
Zimmer Biomet N
Zimmer Biomet N
“The reports are very useful”
-R&D Team Leader
Medinol
Medinol
“Great overall experience with iData Research as a company. The type of research they provide should be part of all new product development efforts.”
-Laszlo Garamszegi, CTO
Aurora Spine
Aurora Spine
“iData provides the best-detailed level analysis for segments and sub-segments of any industry reports available.”
-Medical Device Commercialization Strategist
The Experia Group, LLC
The Experia Group, LLC
“Great products, outstanding customer service.”
-Manager
Zeus Industrial Products, Inc.
Zeus Industrial Products, Inc.
“Most complete data available. Very flexible in providing only the things I needed.”
-Orthopedic Surgeon
Chattanooga Orthopedic Group
Chattanooga Orthopedic Group
iData Research has an ever-expanding medical market intelligence library consisting of focused, in-depth, accurate, and exclusive research you will not find anywhere else. Our highly qualified team of industry analysts follow a structured and independent research methodology designed to provide the most valuable return on actionable market data in the world.
Showing all 2 results
-
In-Vitro Diagnostics Market Report Suite | United States | 2016-2022 | MedSuite
In-Vitro Diagnostics Market Report Suite | United States | 2016-2022 | MedSuite
The fastest-growing segment in 2015 was molecular diagnostics, which increased by 3.6% over the previous year. Growth in the molecular diagnostics market will be driven by increases in the number of Food and Drug Administration (FDA) approved tests and higher penetration of molecular testing in... more... -
In-Vitro Diagnostics Market Report Suite | United States | 2011-2017 | MedSuite
In-Vitro Diagnostics Market Report Suite | United States | 2011-2017 | MedSuite
By 2017, the U.S. in vitro diagnostic market is expected to approach $10 billion. The market segments covered in the U.S. Markets for In Vitro Diagnostics 2011 include: Immunochemistry, – Immunochemistry Analyzer – Immunology Diagnostic – Chemistry Diagnostics –... more...
